What's Trending in Skincare

Regulatory Reckoning in Cosmetics

The cosmetics industry, including skincare, operates under unprecedented regulatory pressure in 2026. The Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022, marked the most significant overhaul of U.S. cosmetics rules since 1938, transforming a largely self-regulated sector into one with proactive FDA authority.

Facility registration renewals, due by July 1, 2026, represent the immediate crunch point. Manufacturers and processors distributing in the U.S. must update their registrations biennially via the FDA's Cosmetics Direct portal, with the agency issuing updated guidance and tools in early 2026 to facilitate compliance.

This deadline arrives against a backdrop of fragmented but intensifying restrictions. Multiple states have implemented bans on intentionally added PFAS in cosmetics effective from January 2025, with more states following suit. Washington's Toxic-Free Cosmetics Act imposes strict lead limits starting in 2025, and similar measures target other chemicals. The FDA's ongoing PFAS assessment, finalized in late 2025, signals potential federal restrictions.

Consumers increasingly demand longevity-oriented products—focusing on regenerative ingredients like peptides, growth factors, and microbiome support—yet regulatory delays on good manufacturing practices (GMP) rules and other MoCRA provisions create uncertainty. Innovation in gentler actives and personalized solutions collides with requirements for adverse event reporting within 15 days and substantiation of safety claims.

Tensions arise between rapid trend adoption—driven by K-beauty influences and AI personalization—and the slower pace of regulatory approval, particularly for novel UV filters or biotech-derived actives. The industry must balance consumer expectations for effective, science-backed products with compliance costs that disproportionately affect smaller brands.

Stakes are high: failure to renew registrations or report issues can trigger FDA enforcement, product seizures, or reputational damage in a market projected to exceed $200 billion globally by the decade's end.